The toolkit identifies the challenges and outlines possible solutions for promoting and accelerating timely and high-quality research and development of antiretroviral drug formulations suitable for infants, children, adolescents and pregnant and breastfeeding women.
The toolkit was developed under the umbrella of the Global Accelerator for Paediatric Formulations initiative to address some of the remaining challenges in developing HIV drugs for children and to serve as a global standard for accelerating high-quality research and development in this field. It provides an opportunity to capitalize on best practices and to set standards that enable drugs and formulations to be developed and introduced more rapidly.
The aim of this toolkit is to facilitate faster, more efficient and focused development of new formulations for the effective treatment of infants, children and adolescents living with HIV by synthesizing key considerations for different stages of the drug development process.
